Outline
Lipids are one of the pillar excipients for drug delivery systems and are especially important for RNA-based therapies such as mRNA vaccines. As a CDMO partner offering end-to-end solutions, Evonik has built up a body of experience and expertise in every step of the manufacturing process such as route scouting, process development, optimization, purification, isolation, characterization, scale-up and commercialization. In this webinar, our experts will introduce Evonik’s new Lipid Launch Facility in Hanau, Germany, and talk through each of these important steps in detail outlining key capabilities for success. Solutions to common challenges are also addressed in this webinar.
Lipids are one of the pillar excipients for drug delivery systems and are especially important for RNA-based therapies such as mRNA vaccines. As a CDMO partner offering end-to-end solutions, Evonik has built up a body of experience and expertise in every step of the manufacturing process such as route scouting, process development, optimization, purification, isolation, characterization, scale-up and commercialization. In this webinar, our experts will introduce Evonik’s new Lipid Launch Facility in Hanau, Germany, and talk through each of these important steps in detail outlining key capabilities for success. Solutions to common challenges are also addressed in this webinar.
